Semmelweis Publications
  • Main page

    • Moldvay, Judit Semmelweis University affiliated publications (2020-2025)

    Year:
    Order by:
    Authorship:
    Number of publications: 47
    1.
    Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1-and IL-6-related systemic inflammation in COVID-19
    Fekete, R;Simats, A;Biró, E;Pósfai, B;Cserép, C;Schwarcz, AD;Szabadits, E;Környei, Z;Tóth, K;Fichó, E;Szalma, J;Vida, S;Kellermayer, A;Dávid, C;Acsády, L;Kontra, L;Silvestre-Roig, C;Moldvay, J;Fillinger, J;Csikász-Nagy, A;Hortobágyi, T;Liesz, A;Benko, S;Dénes, A
    D1
    NATURE NEUROSCIENCE
    2025.
    DOI:10.1038/s41593-025-01871-z (Copy DOI)
    2.
    Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study
    Megyesfalvi, Z;Barany, N;Lantos, A;Valko, Z;Pipek, O;Lang, C;Schwendenwein, A;Oberndorfer, F;Paku, S;Ferencz, B;Dezso, K;Fillinger, J;Lohinai, Z;Moldvay, J;Galffy, G;Szeitz, B;Rezeli, M;Rivard, C;Hirsch, FR;Brcic, L;Popper, H;Kern, I;Kovacevic, M;Skarda, J;Mittak, M;Marko-Varga, G;Bogos, K;Renyi-Vamos, F;Hoda, MA;Klikovits, T;Hoetzenecker, K;Schelch, K;Laszlo, V;Dome, B
    D1
    JOURNAL OF PATHOLOGY
    2022.
    DOI:10.1002/path.5922 (Copy DOI)
    3.
    Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
    Dora, D;Rivard, C;Yu, H;Bunn, P;Suda, K;Ren, SX;Pickard, SL;Laszlo, V;Harko, T;Megyesfalvi, Z;Moldvay, J;Hirsch, FR;Dome, B;Lohinai, Z
    D1
    MOLECULAR ONCOLOGY
    2020.
    DOI:10.1002/1878-0261.12741 (Copy DOI)
    4.
    Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
    Bogos, K;Kiss, Z;Fronius, AK;Temesi, G;Elek, J;Madurka, I;Cselkó, Z;Csányi, P;Abonyi-Tóth, Z;Rokszin, G;Barcza, Z;Moldvay, J
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.1609774 (Copy DOI)
    5.
    Down-regulation of A20 promotes immune escape of lung adenocarcinomas
    Breitenecker, K;Homolya, M;Luca, AC;Lang, V;Trenk, C;Petroczi, G;Mohrherr, J;Horvath, J;Moritsch, S;Haas, L;Kurnaeva, M;Eferl, R;Stoiber, D;Moriggl, R;Bilban, M;Obenauf, AC;Ferran, C;Dome, B;Laszlo, V;Gyorffy, B;Dezso, K;Moldvay, J;Casanova, E;Moll, HP
    D1
    SCIENCE TRANSLATIONAL MEDICINE
    2021.
    DOI:10.1126/scitranslmed.abc3911 (Copy DOI)
    6.
    The landscape of small cell lung cancer metastases: Organ specificity and timing
    Megyesfalvi, Z;Tallosy, B;Pipek, O;Fillinger, J;Lang, C;Klikovits, T;Schwendenwein, A;Hoda, MA;Renyi-Vamos, F;Laszlo, V;Rezeli, M;Moldvay, J;Dome, B
    Q2
    THORACIC CANCER
    2021.
    DOI:10.1111/1759-7714.13854 (Copy DOI)
    7.
    Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011-2019 based on a health insurance fund database
    Kiss, Z;Maráz, A;Rokszin, G;Horváth, Z;Nagy, P;Fábián, I;Kovács, V;Surján, G;Barcza, Z;Kenessey, I;Wéber, A;Wittmann, I;Molnár, GA;Gyöngyösi, E;Buga, V;Darida, M;Szabó, TG;Karamousouli, E;Abonyi-Tóth, Z;Tamás, RB;Fürtos, D;Bogos, K;Moldvay, J;Gálffy, G;Tamási, L;Müller, V;Krasznai, ZT;Ostoros, G;Pápai-Székely, Z;Géczy, GB;Hilbert, L;Polgár, C;Vokó, Z
    Q2
    FRONTIERS IN ONCOLOGY
    2025.
    DOI:10.3389/fonc.2025.1446611 (Copy DOI)
    8.
    Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
    Biswas, D;Liu, YH;Herrero, J;Wu, Y;Moore, DA;Karasaki, T;Grigoriadis, K;Lu, WT;Veeriah, S;Naceur-Lombardelli, C;Magno, N;Ward, S;Frankell, AM;Hill, MS;Colliver, E;Trécesson, SD;East, P;Malhi, A;Snell, DM;O'Neill, O;Leonce, D;Mattsson, J;Lindberg, A;Micke, P;Moldvay, J;Megyesfalvi, Z;Dome, B;Fillinger, J;Nicod, J;Downward, J;Szallasi, Z;Hackshaw, A;Jamal-Hanjani, M;Kanu, N;Birkbak, NJ;Swanton, C
    D1
    NATURE CANCER
    2025.
    DOI:10.1038/s43018-024-00883-1 (Copy DOI)
    9.
    A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
    Diossy, M;Sztupinszki, Z;Borcsok, J;Krzystanek, M;Tisza, V;Spisak, S;Rusz, O;Timar, J;Csabai, I;Fillinger, J;Moldvay, J;Pedersen, AG;Szuts, D;Szallasi, Z
    NPJ PRECISION ONCOLOGY
    2021.
    DOI:10.1038/s41698-021-00199-8 (Copy DOI)
    10.
    Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer
    Dora, D;Weiss, GJ;Megyesfalvi, Z;Gállfy, G;Dulka, E;Kerpel-Fronius, A;Berta, J;Moldvay, J;Dome, B;Lohinai, Z
    Q1
    CANCERS
    2023.
    DOI:10.3390/cancers15205091 (Copy DOI)
    11.
    Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
    Woldmar, N;Schwendenwein, A;Kuras, M;Szeitz, B;Boettiger, K;Tisza, A;László,;Reiniger, L;Bagó, AG;Szállási, Z;Moldvay, J;Szász, AM;Malm, J;Horvatovich, P;Pizzatti, L;Domont, GB;Rényi-Vámos, F;Hoetzenecker, K;Hoda, MA;Marko-Varga, G;Schelch, K;Megyesfalvi, Z;Rezeli, M;Döme, B
    Q1
    ESMO OPEN
    2023.
    DOI:10.1016/j.esmoop.2022.100741 (Copy DOI)
    12.
    Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives
    Kuras, M;Woldmar, N;Kim, Y;Hefner, M;Malm, J;Moldvay, J;Döme, B;Fillinger, J;Pizzatti, L;Gil, J;Marko-Varga, G;Rezeli, M
    Q1
    JOURNAL OF PROTEOME RESEARCH
    2021.
    DOI:10.1021/acs.jproteome.0c00850 (Copy DOI)
    13.
    EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study
    Gieszer, B;Megyesfalvi, Z;Dulai, V;Papay, J;Kovalszky, I;Timar, J;Fillinger, J;Harko, T;Pipek, O;Teglasi, V;Regos, E;Papp, G;Szallasi, Z;Laszlo, V;Renyi-Vamos, F;Galffy, G;Bodor, C;Dome, B;Moldvay, J
    Q2
    TRANSLATIONAL LUNG CANCER RESEARCH
    2021.
    DOI:10.21037/tlcr-20-814 (Copy DOI)
    14.
    Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models
    Sándor, GO;Soós, AA;Lörincz, P;Rojkó, L;Harkó, T;Bogyó, L;Tölgyes, T;Bursics, A;Buzás, EI;Moldvay, J;Wiener, Z
    Q1
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
    2021.
    DOI:10.3389/fcell.2021.670825 (Copy DOI)
    15.
    Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
    Tamasi, L;Horváth, K;Kiss, Z;Bogos, K;Ostoros, G;Müller, V;Urbán, L;Bittner, N;Sárosi, V;Vastag, A;Polányi, Z;Nagy-Erdei, Z;Daniel, A;Nagy, B;Rokszin, G;Abonyi-Tóth, Z;Moldvay, J;Vokó, Z;Gálffy, G
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.598862 (Copy DOI)
    16.
    Analysis and characterization of chondroitin/dermatan sulfate composition of lung adenocarcinoma tissues with different types of genetic alterations in ALK, EGFR and KRAS oncogenes
    Pál, D;Bugyi, F;Virág, D;Szabó, D;Schlosser, G;Kovalszky, I;Harkó, T;Moldvay, J;Turiák, L
    Q1
    CARBOHYDRATE POLYMER TECHNOLOGIES AND APPLICATIONS
    2025.
    DOI:10.1016/j.carpta.2025.100826 (Copy DOI)
    17.
    Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
    Kiss, Z;Gálffy, G;Müller, V;Moldvay, J;Sárosi, V;Pápai-Székely, Z;Csada, E;Kerpel-Fronius, A;Király, Z;Szász, Z;Hódi, G;Polányi, Z;Kovács, K;Karamousouli, E;Knollmajer, K;Szabo, TG;Berta, A;Vokó, Z;Rokszin, G;Abonyi-Tóth, Z;Barcza, Z;Tamási, L;Bogos, K
    Q2
    FRONTIERS IN ONCOLOGY
    2023.
    DOI:10.3389/fonc.2023.1207295 (Copy DOI)
    18.
    Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016
    Bogos, K;Kiss, Z;Tamási, L;Ostoros, G;Müller, V;Urbán, L;Bittner, N;Sárosi, V;Vastag, A;Polányi, Z;Nagy-Erdei, Z;Daniel, A;Vokó, Z;Nagy, B;Horváth, K;Rokszin, G;Abonyi-Tóth, Z;Barcza, Z;Gálffy, G;Moldvay, J
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.603937 (Copy DOI)
    19.
    Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources
    Gálffy, G;Szabó, GT;Tamási, L;Müller, V;Moldvay, J;Sárosi, V;Kerpel-Fronius, A;Kardos, T;Csada, E;Pápai-Székely, Z;Szász, Z;Király, Z;Hódi, G;Kovács, Z;Balogh, E;Kovács, KA;Darida, M;Buga, V;Rokszin, G;Abonyi-Tóth, Z;Kiss, Z;Vokó, Z;Bogos, K
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2024.
    DOI:10.3389/pore.2024.1611754 (Copy DOI)
    20.
    BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
    Dora, D;Vörös, I;Varga, ZV;Takacs, P;Teglasi, V;Moldvay, J;Lohinai, Z
    Q1
    TRANSLATIONAL LUNG CANCER RESEARCH
    2023.
    DOI:10.21037/tlcr-22-449 (Copy DOI)
    21.
    Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain
    Ramanathan, JT;Lehtipuro, S;Sihto, H;Tóvári, J;Reiniger, L;Téglási, V;Moldvay, J;Nykter, M;Haapasalo, H;Le Joncour, V;Laakkonen, P
    Q1
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
    2020.
    DOI:10.1111/jcmm.15350 (Copy DOI)
    22.
    Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
    Galffy, G;Vastag, A;Bogos, K;Zoltan, K;Ostoros, G;Müller, V;Urbán, L;Bittner, N;Sárosi, V;Polányi, Z;Nagy-Erdei, Z;Daniel, A;Knollmajer, K;Várnai, M;Szegner, P;Vokó, Z;Nagy, B;Horváth, K;Rokszin, G;Abonyi-Tóth, Z;Pozsgai, E;Barcza, Z;Moldvay, J;Tamási, L
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.1609916 (Copy DOI)
    23.
    Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
    Oo, HZ;Lohinai, Z;Khazamipour, N;Lo, J;Kumar, G;Pihl, J;Adomat, H;Nabavi, N;Behmanesh, H;Zhai, B;Dagil, R;Choudhary, S;Gustavsson, T;Clausen, TM;Esko, JD;Allen, JW;Thompson, MA;Tran, NL;Moldvay, J;Dome, B;Salanti, A;Al-Nakouzi, N;Weiss, GJ;Daugaard, M
    Q1
    CANCERS
    2021.
    DOI:10.3390/cancers13174489 (Copy DOI)
    Semmelweis University authors: Lohinai, Zoltán, Moldvay, Judit, Döme, Balázs,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Thoracic Surgery,
    24.
    PD-1 and PD-L1 expression in rare lung tumors
    Gyulai, M;Megyesfalvi, Z;Reiniger, L;Harko, T;Ferencz, B;Karsko, L;Agocs, L;Fillinger, J;Dome, B;Szallasi, Z;Moldvay, J
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2023.
    DOI:10.3389/pore.2023.1611164 (Copy DOI)
    25.
    Revising cancer incidence in a Central European country: a Hungarian nationwide study between 2011-2019 based on a health insurance fund database
    Kiss, Z;Szabó, TG;Polgár, C;Horváth, Z;Nagy, P;Fábián, I;Kovács, V;Surján, G;Barcza, Z;Kenessey, I;Wéber, A;Wittmann, I;Molnár, GA;Gyöngyösi, E;Benedek, A;Karamousouli, E;Abonyi-Tóth, Z;Tamás, RB;Fürtos, DV;Bogos, K;Moldvay, J;Gálffy, G;Tamási, L;Müller, V;Krasznai, ZT;Ostoros, G;Pápai-Székely, Z;Maráz, A;Géczy, GB;Hilbert, L;Berki, LT;Rokszin, G;Vokó, Z
    Q2
    FRONTIERS IN ONCOLOGY
    2024.
    DOI:10.3389/fonc.2024.1393132 (Copy DOI)
    26.
    Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study
    Balbisi, M;Sugár, S;Schlosser, G;Szeitz, B;Fillinger, J;Moldvay, J;Drahos, L;Szász, AM;Tóth, G;Turiák, L
    D1
    SCIENTIFIC REPORTS
    2023.
    DOI:10.1038/s41598-023-33435-1 (Copy DOI)
    27.
    KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges
    Moldvay, J;Timár, J
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2024.
    DOI:10.3389/pore.2023.1611580 (Copy DOI)
    28.
    Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
    Radeczky, P;Moldvay, J;Fillinger, J;Szeitz, B;Ferencz, B;Boettiger, K;Rezeli, M;Bogos, K;Renyi-Vamos, F;Hoetzenecker, K;Hegedus, B;Megyesfalvi, Z;Dome, B
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.1609926 (Copy DOI)
    29.
    Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients
    Incze, E;Mangó, K;Fekete, F;Kiss, AF;Póti, A;Harkó, T;Moldvay, J;Szüts, D;Monostory, K
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms241713380 (Copy DOI)
    Semmelweis University authors: Moldvay, Judit,
    Semmelweis University departments: Semmelweis University, School of PhD Studies,
    30.
    Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity
    Szeitz, B;Glasz, T;Herold, Z;Tóth, G;Balbisi, M;Fillinger, J;Horváth, S;Mohácsi, R;Kwon, HJ;Moldvay, J;Turiák, L;Szász, AM
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms241411369 (Copy DOI)
    31.
    Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma
    Gyulai, M;Harko, T;Fabian, K;Karsko, L;Agocs, L;Szigeti, B;Fillinger, J;Szallasi, Z;Pipek, O;Moldvay, J
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2023.
    DOI:10.3389/pore.2023.1611328 (Copy DOI)
    32.
    Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations
    Abdelwahab, EMM;Bovari-Biri, J;Smuk, G;Harko, T;Fillinger, J;Moldvay, J;Krymskaya, VP;Pongracz, JE
    Q1
    FRONTIERS IN ONCOLOGY
    2021.
    DOI:10.3389/fonc.2021.644592 (Copy DOI)
    33.
    Underlying reasons for post-mortem diagnosed lung cancer cases - A robust retrospective comparative study from Hungary (HULC study)
    Kiss, ZN;Bogos, K;Tamási, L;Ostoros, G;Müller, V;Bittner, N;Sárosi, V;Vastag, A;Knollmajer, K;Várnai, M;Kovács, K;Berta, A;Köveskuti, I;Karamousouli, E;Rokszin, G;Abonyi-Tóth, Z;Barcza, Z;Kenessey, I;Weber, A;Nagy, P;Freyler-Fadgyas, P;Szócska, M;Szegner, P;Hilbert, L;Géczy, GB;Surján, G;Moldvay, J;Vokó, Z;Gálffy, G;Polányi, Z
    Q2
    FRONTIERS IN ONCOLOGY
    2022.
    DOI:10.3389/fonc.2022.1032366 (Copy DOI)
    34.
    The effects of bisphosphonate and radiation therapy in bone- metastatic lung adenocarcinoma: the impact of KRAS mutation
    Radeczky, P;Megyesfalvi, Z;Laszlo, V;Fillinger, J;Moldvay, J;Raso, E;Schlegl, E;Barbai, T;Timar, J;Renyi-Vamos, F;Dome, B;Hegedus, B
    Q2
    TRANSLATIONAL LUNG CANCER RESEARCH
    2021.
    DOI:10.21037/tlcr-20-754 (Copy DOI)
    35.
    A tüdőrák hazai epidemiológiai adatai új megközelítésben
    Bogos, Krisztina; Kiss, Zoltán; Gálffy, Gabriella; Tamási, Lilla; Ostoros, Gyula; Müller, Veronika; Urbán, László; Bittner, Nóra; Sárosi, Veronika; Vastag, Aladár; Polányi, Zoltán; Nagy-Erdei, Zsófia; Vokó, Zoltán; Nagy, Balázs; Rokszin, György; Abonyi-Tóth, Zsolt; Moldvay, Judit;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2020.
    36.
    Application of a Receptor-Binding-Domain-Based Simple Immunoassay for Assessing Humoral Immunity against Emerging SARS-CoV-2 Virus Variants
    Mozner, O;Moldvay, J;Szabo, KS;Vasko, D;Domjan, J;Acs, D;Ligeti, Z;Feher, C;Hirsch, E;Puskas, L;Stahl, C;Frey, M;Sarkadi, B;Gudowska-Sawczuk, M;Zajkowska, M
    Q1
    BIOMEDICINES
    2023.
    DOI:10.3390/biomedicines11123193 (Copy DOI)
    Semmelweis University authors: Mózner, Orsolya, Moldvay, Judit, Sarkadi, Balázs,
    Semmelweis University departments: Semmelweis University, School of PhD Studies,
    37.
    Longitudinal analysis of complete blood count parameters in advanced-stage lung cancer patients
    Rojko, L;Megyesfalvi, Z;Czibula, E;Reiniger, L;Teglasi, V;Szegedi, Z;Szallasi, Z;Dome, B;Moldvay, J
    Q2
    THORACIC CANCER
    2020.
    DOI:10.1111/1759-7714.13642 (Copy DOI)
    38.
    Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary
    Kiss, Z;Bogos, K;Tamasi, L;Ostoros, G;Mueller, V;Urban, L;Bittner, N;Sarosi, V;Vastag, A;Polanyi, Z;Nagy-Erdei, Z;Knollmajer, K;Varnai, M;Nagy, B;Horvath, K;Rokszin, G;Abonyi-Toth, Z;Barcza, Z;Moldvay, J;Galffy, G;Voko, Z
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.1610041 (Copy DOI)
    39.
    A kissejtes tüdőrák heterogenitásának biológiai és klinikopatológiai jelentősége
    Megyesfalvi, Zsolt; Bárány, Nándor; Valkó, Zsuzsanna; Bugyik, Edina; Paku, Sándor; Berta, Judit; Lantos, András; Fillinger, János; Moldvay, Judit; Bogos, Krisztina; Rezeli, Melinda; Gálffy, Gabriella; Lang, Christian; Lohinai, Zoltán; Hécz, Réka; Lovas, Tímea; Rényi-Vámos, Ferenc; László, Viktória; Döme, Balázs;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2020.
    40.
    Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas
    Papp, E;Steib, A;Abdelwahab, EMM;Meggyes-Rapp, J;Jakab, L;Smuk, G;Schlegl, E;Moldvay, J;Sárosi, V;Pongracz, JE
    Q1
    BMJ OPEN RESPIRATORY RESEARCH
    2020.
    DOI:10.1136/bmjresp-2019-000505 (Copy DOI)
    Semmelweis University authors: Moldvay, Judit,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Pulmonology,
    41.
    Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity
    Mózner, O;Szabó, E;Kulin, A;Várady, G;Moldvay, J;Vass, V;Szentesi, A;Jánosi, A;Hegyi, P;Sarkadi, B
    Q1
    PLOS ONE
    2025.
    DOI:10.1371/journal.pone.0316396 (Copy DOI)
    42.
    Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations
    Bugyi, F;Balbisi, M;Sugár, S;Váncza, L;Regos, E;Kovalszky, I;Laczó, I;Harkó, T;Kecskeméti, G;Szabó, Z;Moldvay, J;Drahos, L;Turiák, L
    D1
    MOLECULAR ONCOLOGY
    2025.
    DOI:10.1002/1878-0261.70091 (Copy DOI)
    43.
    Overall Survival of Hungarian Cancer Patients Diagnosed Between 2011 and 2019, Based on the Health Insurance Fund Database
    Kiss, Z;Berki, TL;Maraz, A;Horváth, Z;Nagy, P;Fabian, I;Kovács, V;Rokszin, G;Surján, G;Barcza, Z;Kenessey, I;Wéber, A;Wittmann, I;Molnar, GA;Szabo, TG;Buga, V;Karamousouli, E;Darida, M;Abonyi-Tóth, Z;Tamás, RB;Fürtos, VD;Bogos, K;Moldvay, J;Gálffy, G;Tamasi, L;Müller, V;Krasznai, ZT;Ostoros, G;Papai-Székely, Z;Géczy, GB;Hilbert, L;Polgár, C;Vokó, Z
    Q1
    CANCERS
    2025.
    DOI:10.3390/cancers17101670 (Copy DOI)
    44.
    A KRAS-mutációs státusz prediktív szerepe biszfoszfonáttal kezelt, csontáttétet képző tüdő-adenokarcinómában [Predictive relevance of KRAS mutational status in bone metastatic lung adenocarcinoma treated with bisphosphonate therapy]
    Radeczky, Péter; Megyesfalvi, Zsolt; Fillinger, János; László, Viktória; Rásó, Erzsébet; Moldvay, Judit; Schlegl, Erzsébet; Barbai, Tamás; Bogos, Krisztina; Tímár, József; Rényi-Vámos, Ferenc; Hegedűs, Balázs; Döme, Balázs;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2021.
    45.
    A koronavírussal összefüggő halálozás vizsgálata Magyarországon és a Visegrádi Együttműködés országaiban 2020-2021-ben
    Kenessey, István; Abonyi-Tóth, Zsolt; Bogos, Krisztina; Kerpel-Fronius, Anna; Kiss, Zoltán; Moldvay, Judit; Roxin, György; Surján, Orsolya; Wéber, András; Wittmann, István; Surján, György; Kásler, Miklós;
    MAGYAR BELORVOSI ARCHIVUM 0133-5464
    2022.
    46.
    A nem reszekábilis stádiumú, szisztémás kezelésben részesülő tüdő adenocarcinomás betegek túlélésének változása 2011 és 2023 között
    Bogos, Krisztina; Müller, Veronika; Gálffy, Gabriella; Moldvay, Judit; Sárosi, Veronika; Pápai-Székely, Zsolt; Csada, Edit; Rokszin, György; Abonyi-Tóth, Zsolt; Ostoros, Gyula; Kardos, Tamás; Tamási, Lilla;
    MEDICINA THORACALIS (BUDAPEST) 0238-2571
    2024.
    47.
    Tüdő-adenokarcinómák molekuláris patológiai vizsgálata, EGFR T790M rezisztenciamutáció-vizsgálatok [Molecular pathology of lung adenocarcinomas, EGFR T790M resistance mutation study]
    Kohánka, Andrea; Báthory-Fülöp, László; Tanács-Bencze, Eszter; Engi, Helga; Bogos, Krisztina; Moldvay, Judit; Pápai, Székely Zsolt; Szalai, Zsuzsanna; Szőke, János; Tóth, Erika;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2024.

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_11
    Department data last refreshed at: 06.11.2025
    Author data last refreshed at: 06.11.2025
    (c) Semmelweis University - Central Library